Jason Turpin

Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment.

B. Hendriks, G. Sahagian, W. Kamoun, 2019, Nanomedicine : nanotechnology, biology, and medicine.

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

O. Griffith, G. Mills, J. Gray, 2016, Oncogene.

Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.

G. Mills, L. Chodosh, M. Hallett, 2016, Cancer research.

Reverse Transcription of Human Immunodeficiency Virus Type 1 is Blocked by Retroviral Zinc Finger Inhibitors

L. Graham, M. Bu, Jason Turpin, 1997 .

Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development

D. Huntsman, K. Cianflone, J. Ursini-Siegel, 2007, Molecular and Cellular Biology.

Investigating the Role of Fatty Acid Metabolism and DecR1 Expression ErbB2-Driven Mammary Tumorigenesis and Metastasis Using a Transgenic Mouse Model Approach

Jason Turpin, 2011 .